Project Grant R43GM154546

Award Date 5/1/24
Completion Date 2/28/25
Dollars Obligated $883K
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Bloomington, IN, USA
Similar Awards
The National Institute of General Medical Sciences (NIGMS) awarded a $265,939 project grant under the Biomedical Research and Research Training program (CFDA 93.859) to Trustees of Indiana University, doing business as Indiana University, to advance high-resolution charge detection-mass spectrometry (CD-MS) technology. The project aims to address the two main limitations of CD-MS: its moderate resolving power and the relatively long time needed to measure a spectrum. Key objectives include...
This federal Project Grant award in the amount of $271,495.00, provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), supports the development and evaluation of a time-of-flight (TOF) mass spectrometer system with matrix-assisted laser desorption/ionization (MALDI) for fast analysis of antibodies and related macromolecular immune complexes. The goal is to utilize a novel high-temperature superconducting...
The National Science Foundation's Integrative Activities (CFDA 47.083) program has awarded a $350,000 Project Grant to the College of Charleston to acquire a MALDI-TOF/TOF mass spectrometer instrument. This state-of-the-art equipment will enable new research directions, encourage cross-disciplinary collaborations, and provide hands-on training for a diverse population of undergraduate students and researchers at the college and across the Lowcountry region of South Carolina. The mass...
The National Institutes of Health (NIH) awarded a $1,352,820 Project Grant under the Research Infrastructure Programs (CFDA 93.351) to the Massachusetts General Hospital (MGH) to acquire a novel high-throughput and high-sensitivity mass spectrometer called the Orbitrap Astral. This state-of-the-art instrument will be used to conduct proteomic research focused on cancer and Alzheimer's disease at MGH. The Orbitrap Astral's unprecedented speed and sensitivity are expected to enable new...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under CFDA 93.859 Biomedical Research and Research Training program provides $306,860 to Mixedlcmedia LLC, a small disadvantaged business, to develop and evaluate a prototype ultra-low flow liquid chromatography platform based on their proprietary porous layer open-tubular (PLOT) and monolithic nanocolumn technologies. The goal is to create a commercialization-ready LC system that enables deep proteomic...
This Project Grant award from the National Institutes of Health's (NIH) Office of Research Infrastructure Programs (CFDA 93.351 - Research Infrastructure Programs) provides $1,574,994 to the University of California, Los Angeles (UCLA) to acquire a high-resolution tandem mass spectrometer. This state-of-the-art instrument will support over 11 NIH-funded research projects focused on characterizing the structure of a broad range of large biological and synthetic molecules, including proteins,...
This National Science Foundation (NSF) Cooperative Agreement award, funded under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program, supports the development of a novel, miniaturized ion trap mass spectrometer technology by Ionicscale LLC, a small technology company. The $1,000,000 project aims to create an ultra-compact, remotely programmable chemical analyzer that can greatly expand the accessibility and affordability of mass spectrometry-based chemical detection and...
The National Institute of General Medical Sciences (NIGMS) awarded a $3,895,802 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to GMJ Technologies, Inc., a minority-owned small disadvantaged business. The grant, awarded on August 1, 2024, supports the development of a high-resolution native capillary zone electrophoresis system with inline UV and native mass spectrometry capabilities for characterizing charge variants in biologics. The proposed technology...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) will support a high-risk, high-reward effort to improve the sensitivity and selectivity of laser desorption ionization for mass spectrometry-based proteomics applications. The $247,767 award, effective September 1, 2024 through August 31, 2026, will enable researchers at the University of Notre Dame to develop proof-of-concept experiments...
This National Science Foundation Technology, Innovation, and Partnerships Project Grant of $256,000 will support the development of a novel mass spectrometer by Moires Instruments, LLC to identify molecular isomers and distinguish their conformational forms. The instrument uses high electric fields to manipulate neutral molecules based on their dipole moments, separating them by mass-to-dipole-moment ratio rather than conventional mass-to-charge ratio. This approach aims to reduce the...

MULTI-DETECTOR ARRAY CD-MS FOR RAPID ANALYSIS OF VERY HIGH MASS ANALYTES - PROJECT SUMMARY/ABSTRACT THIS PROPOSAL DESCRIBES KEY STEPS TOWARDS DESIGNING A HIGH-THROUGHPUT CHARGE DETECTION MASS SPECTROMETER THAT IS OPTIMIZED FOR VERY HIGH MASS PARTICLES IN THE MEGADALTON AND GIGADALTON MASS RANGE. CHARGE DETECTION MASS SPECTROMETRY (CD-MS) IS AN EMERGING TECHNOLOGY CAPABLE OF ACCURATELY MEASURING THE MASS OF LARGE AND HETEROGENEOUS ANALYTES, MAKING IT HIGHLY SUITABLE FOR A WIDE ARRAY OF APPLICATIONS INCLUDING BIOPHARMACEUTICALS INCLUDING GENE THERAPY VECTORS, VIRUS PARTICLES SUCH AS ADENOVIRUS AND LENTIVIRUS, LIPOSOMES, AND LARGE MIOMARKERS SUCH AS LIPOPROTEINS AND EXOSOMES. CD-MS OFTEN EMPLOYS AN ELECTROSTATIC ION TRAP CONTAINING A CONDUCTIVE DETECTION CYLINDER CONNECTED TO A CHARGE SENSITIVE AMPLIFIER. TRAPPED IONS REPEATEDLY PASS THROUGH THE DETECTION CYLINDER, GENERATING A SQUARE WAVE SIGNAL, AND ARE INDIVIDUALLY ANALYZED BY FAST FOURIER TRANSFORM FOR THEIR MASS-TO-CHARGE RATIO (M/Z) AND CHARGE BY MEASURING THEIR OSCILLATION FREQUENCY AND SIGNAL MAGNITUDE, RESPECTIVELY. WHILE A TRAP OFFERS THE HIGHEST CHARGE RESOLUTION, AND THEREFORE THE HIGHEST MASS RESOLUTION, IT SUFFERS FROM LOW SENSITIVITY AND CAN BE TIME-CONSUMING. FOR EXAMPLE, ROUTINE MASS SPECTRUM ACQUISITION TAKES AROUND 15 MINUTES FOR A SAMPLE WITH 1012 PARTICLES/ML AND THE LOWER DETECTION LIMIT IS APPROXIMATELY 1010 PARTICLES/ML. LOWER CONCENTRATIONS ALSO REQUIRE LONGER TO ANALYZE. IN THIS PROPOSAL WE AIM TO DESIGN A DETECTOR ARRAY CD-MS INSTRUMENT CAPABLE OF ENHANCING THE SENSITIVITY AND THROUGHPUT BY TWO ORDERS OF MAGNITUDE FOR HETEROGENEOUS SAMPLES WHERE HIGHER MASS RESOLUTION IS NOT NECESSARY FOR ACCURATELY CHARACTERIZING THE MASS DISTRIBUTION. THIS ARRAY WILL CONSIST OF TEN INDIVIDUAL DETECTION CYLINDERS IN A LINEAR ARRANGEMENT. IONS WILL BE FLOWN THROUGH THE ARRAY AND REFOCUSED TOWARDS THE CENTRAL AXIS BY ELECTROSTATIC LENSES. CHARGE SENSITIVE AMPLIFIERS AND ANALOG TO DIGITAL CONVERTERS WILL GENERATE AND SEND SIGNALS FROM EACH DETECTOR TO A CENTRAL PROCESSING UNIT SUCH AS A FIELD-PROGRAMMABLE GATE ARRAY (FPGA) FOR THE SIGNALS TO BE PACKAGED INTO FILES AND THEN SENT TO A SERVER FOR DATA PROCESSING. IN THIS INVESTIGATION, DEVELOPMENT WILL BEGIN BY PERFORMING ION TRAJECTORY SIMULATIONS FOR OPTIMIZING GEOMETRIC PARAMETERS OF THE ARRAY AND FOCUSING VOLTAGES APPLIED TO THE LENSES TO MAXIMIZE ION TRANSMISSION THROUGH THE ARRAY, THEREBY MAXIMIZING SENSITIVITY. THESE TRAJECTORIES WILL THEN BE USED TO GENERATE REPRESENTATIVE SIMULATED SIGNALS. FOLLOWING FROM THAT, CODE WILL BE WRITTEN TO EXTRACT THE ION M/Z AND CHARGE FROM THE SIMULATED SIGNALS. ALONGSIDE CODE DEVELOPMENT, WE WILL EXPLORE DIFFERENT AMPLIFIER CONFIGURATIONS THAT GIVE RISE TO THE FASTEST ANALYSIS AND BEST CHARGE DETERMINATION. FINALLY, WE WISH TO DEVELOP AN INTEGRATED CIRCUIT FOR CD-MS AMPLIFIERS WHICH HAS THE POTENTIAL TO SIGNIFICANTLY IMPROVE THE CHARGE MEASUREMENT PRECISION AND WILL HAVE A MORE ROBUST AND REPRODUCIBLE CONSTRUCTION THAN THE CURRENT CUSTOM AMPLIFIER DESIGN. THE DEVELOPMENT OF THIS HIGH-THROUGHPUT CD-MS ARRAY IS KEY TO MEETING THE NEED FOR AN INSTRUMENT CAPABLE OF ACCURATELY AND RAPIDLY CHARACTERIZING THE MASS DISTRIBUTION OF VERY HEAVY BIOLOGICAL ANALYTES.

Posted 4/18/24, 12:00 AM